Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01082900 · ClinicalTrials.gov registry record · NA
Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial
A NA study of Transient Tachypnea, sponsored by New York Hospital Queens.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
- 1
- Study location
NCT01082900 is a NA study of Transient Tachypnea that has completed, run by New York Hospital Queens. The registered enrollment target is 138 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01082900, a NA study of Transient Tachypnea, has completed, sponsored by New York Hospital Queens.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
- 1
- Study location
Study Summary
Transient Tachypnea of the Newborn (TTN) is a disorder of delayed clearance of lung liquid and a common cause of admission of full term infants and late pre term infants (34 to 36 weeks) to Neonatal Intensive Care Units (NICU). Both late preterm gestational age at delivery, and mode of delivery are considered risk factors for TTN. The investigators hypothesize that CPAP administered prophylactically in the Delivery Room via a T piece based infant resuscitator Neopuff, to neonates at increased risk for TTN, would decrease the incidence of TTN and thus decrease the need for hospitalization in the NICU. This is a pilot study to evaluate the prophylactic administration of CPAP in the Delivery Room towards prevention of TTN and it's effects on natriuretic peptides.The study will be conducted as a randomized control trial after obtaining informed consents from the parents of eligible infants. Infants will be randomized to receive either experimental treatment (prophylactic CPAP) or standardized care.
Conditions Studied
Interventions
- OTHER Prophylactic CPAP Administration
Study Locations (1)
New York
- New York Hospital Queens - Flushing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2009-11 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01082900
The ClinicalTrials.gov registry entry for NCT01082900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Hospital Queens, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Transient Tachypnea appearing as the primary indexed condition, and to 1 intervention - of which Prophylactic CPAP Administration is the first listed.
NCT01082900 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01082900 about?
NCT01082900 is a clinical study titled "Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial". Transient Tachypnea of the Newborn (TTN) is a disorder of delayed clearance of lung liquid and a common cause of admission of full term infants and late pre term infants (34 to 36 weeks) to Neonatal Intensive Care Units (NICU). Both late preterm gestational age at delivery, and mode of delivery are ...
What is the current status of trial NCT01082900?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2009-11. Estimated completion is 2013-04.
What conditions does trial NCT01082900 study?
This clinical trial studies the following conditions: Transient Tachypnea.
What interventions are being tested in trial NCT01082900?
The interventions under investigation include: Prophylactic CPAP Administration (OTHER).
Who is sponsoring clinical trial NCT01082900?
This trial is sponsored by New York Hospital Queens, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01082900 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.